Skip to Content

Ultomiris Prices, Coupons and Patient Assistance Programs

Ultomiris (ravulizumab) is a member of the selective immunosuppressants drug class and is commonly used for Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria.

Ultomiris Prices

This Ultomiris price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Ultomiris intravenous solution (10 mg/mL) is around $6,695 for a supply of 30 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intravenous Solution

10 mg/mL Ultomiris intravenous solution
from $6,695.28 for 30 milliliters
Quantity Per unit Price
30 milliliters $223.18 $6,695.28

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Ultomiris Coupons and Rebates

Ultomiris offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Patient Assistance Programs for Ultomiris

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: OneSource Patient Support Program from Alexion

Elligibility requirements:

  1. Determined case by case
  2. Determined case by case
  3. FDA-approved diagnosis
  4. Must be treated by US licensed healthcare provider
  5. Insurance benefits, claims assistance, or other reimbursement help is offered. This program also provides copay assistance.

Applicable drugs:

  • Ultomiris (ravulizumab-cwvz) Injection; IV
Hide